(1E)-CFI-400437 dihydrochloride
Cat.No:IC6270 Solarbio
CAS:1247000-76-5
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Cell Cycle >
(1E)-CFI-400437 dihydrochlorideCAS:1247000-76-5
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Solid
Qty:
Size:
CAS | 1247000-76-5 |
Name | (1E)-CFI-400437 dihydrochloride |
Molecular Formula | C29H30Cl2N6O2 |
Molecular Weight | 565.5 |
Solubility | Soluble in DMSO ≥1mg/mL(Need ultrasonic) |
Purity | ≥98% |
Appearance | Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD30347423 |
SMILES | CN1CCN(CC1)C2=NC=C(C=C2)/C=C/C3=C4C=CC(=CC5=C(NC6=C5C=C(C=C6)OC)O)C=C4N=N3.Cl.Cl |
InChIKey | NYCYUHRNBLSJAP-XPDSEMQYSA-N |
InChI | InChI=1S/C29H28N6O2.2ClH/c1-34-11-13-35(14-12-34)28-10-5-19(18-30-28)4-8-26-22-7-3-20(16-27(22)33-32-26)15-24-23-17-21(37-2)6-9-25(23)31-29(24)36;;/h3-10,15-18,31,36H,11-14H2,1-2H3;2*1H/b8-4+,20-15 ;; |
PubChem CID | 136351064 |
Target Point | PLK4 |
Passage | Cell Cycle |
Background | (1E) - CFI-400437 dihydrochloride is an effective PLK4 and selective for other members of the PLK family. (1E) - CFI-400437 dihydrochloride also inhibits Aurora A, Aurora B, KDR, and FLT-3. It has anti proliferative activity. |
Biological Activity | (1E)-CFI-400437 dihydrochloride is a potent PLK4 (IC50= 0.6 nM) inhibitor and selective against other members of the PLK family (>10 μM). (1E)-CFI-400437 dihydrochloride inhibits Aurora A, Aurora B, KDR and FLT-3 with IC50s of 0.37, 0.21, 0.48, and 0.18 μM, respectively. Antiproliferative activity[1]. |
IC50 | PLK3:0.6nM [1] |
In Vivo | The plasma levels of(1E)-CFI-400437(50 mg/kg; IP; mice)dihydrochloride shows a Cmax of 92 ng/mL and AUC of 190 ng h/mL,respectively. The mouse plasma protein binding measurement for(1E)-CFI-400437 is 99%,i.e.,unbound compound in plasma is 1%[1]. |
Data Literature Source | [1]. Laufer R,et al. The discovery of PLK4 inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as novel antiproliferative agents. J Med Chem. 2013;56(15):6069-6087 |
Unit | Bottle |
Specification | 1mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.